Expression of the chemokine IP‐10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation

The factors influencing lymphocyte trafficking to the liver lobule during chronic hepaititis C virus (HCV) infection are currently not well defined. Interferon‐γ‐inducible protein 10 (IP‐10), a chemokine that recruits activated T lymphocytes, has recently been shown by in situ hybridization to be expressed in the liver during chronic HCV infection. This study sought to define the cellular source of IP‐10 in the liver by immunohistochemistry, to examine the expression of its receptor, CXCR3, on T lymphocytes isolated from blood and liver tissue, and to correlate IP‐10 expression with the histological markers of inflammation and fibrosis. IP‐10 was expressed by hepatocytes but not by other cell types within the liver, and the most intense immunoreactivity was evident in the areas of lobular inflammation. The IP‐10 receptor was expressed on a significantly higher proportion of T lymphocytes in the liver compared with blood. CD8 T lymphocytes, which predominate in the liver lobule, were almost uniformly CXCR3‐positive. The expression of IP‐10 mRNA correlated with lobular necroinflammatory activity but not with inflammation or fibrosis in the portal tracts. These findings suggest that IP‐10 may be induced by HCV within hepatocytes and may be important in the pathogenesis of chronic HCV infection, as recruitment of inflammatory cells into the lobule is an important predictor of disease progression.

[1]  M. Law,et al.  The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. , 2003, Journal of hepatology.

[2]  P. Manow ‚The Good, the Bad, and the Ugly‘ , 2002 .

[3]  A. Khoruts,et al.  Visualizing the generation of memory CD4 T cells in the whole body , 2001, Nature.

[4]  L. Lefrançois,et al.  Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue , 2001, Science.

[5]  T. Okanoue,et al.  Increase of chemokine interferon‐inducible protein‐10 (IP‐10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes , 2001, Clinical and experimental immunology.

[6]  M. Serio,et al.  Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. , 2001, The Journal of clinical investigation.

[7]  O. Kutsch,et al.  Induction of the Chemokines Interleukin-8 and IP-10 by Human Immunodeficiency Virus Type 1 Tat in Astrocytes , 2000, Journal of Virology.

[8]  M. Burdick,et al.  The ratio of ELR+ to ELR− CXC chemokines affects the lung and liver injury following hepatic ischemia/reperfusion in the rat , 2000, Hepatology.

[9]  E. Brunt,et al.  Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond , 2000, Hepatology.

[10]  D. Adams,et al.  Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. , 1999, Journal of immunology.

[11]  R. Strieter,et al.  The role of chemokines in the immunopathology of pulmonary disease. , 1999, Forum.

[12]  C. O’Farrelly,et al.  Prometheus through the looking glass: reflections on the hepatic immune system. , 1999, Immunology today (Amsterdam. Regular ed.).

[13]  C. Mackay,et al.  Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. , 1998, Immunology today.

[14]  V. Agnello,et al.  Detection of widespread hepatocyte infection in chronic hepatitis C , 1998, Hepatology.

[15]  J. Flier,et al.  Chemokine IP-10 expression in cultured human keratinocytes , 1998, Archives of Dermatological Research.

[16]  M. Baggiolini Chemokines and leukocyte traffic , 1998, Nature.

[17]  C. Mackay,et al.  Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.

[18]  S. Hübscher Histological grading and staging in chronic hepatitis: clinical applications and problems. , 1998, Journal of hepatology.

[19]  M. Koziel The role of immune responses in the pathogenesis of hepatitis C virus infection , 1997, Journal of viral hepatitis.

[20]  M. Shin,et al.  Induction of IP-10 chemokine promoter by measles virus: comparison with interferon-γ shows the use of the same response element but with differential DNA–protein binding profiles , 1997, Journal of Neuroimmunology.

[21]  Y. Tominaga,et al.  Expression of IFN-inducible protein-10 in chronic hepatitis. , 1997, Journal of immunology.

[22]  O. Schiraldi,et al.  In‐situ immunophenotyping study of hepatic‐infiltrating cytotoxic cells in chronic active hepatitis C , 1997, European journal of gastroenterology & hepatology.

[23]  D. Adams,et al.  Chemokines: leucocyte recruitment and activation cytokines , 1997, The Lancet.

[24]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[25]  V. Paradis,et al.  Histological features predictive of liver fibrosis in chronic hepatitis C infection. , 1996, Journal of clinical pathology.

[26]  A. Sher,et al.  Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. , 1996, Journal of immunology.

[27]  R. Purcell,et al.  Hepatitis C virus-associated fulminant hepatic failure. , 1996, The New England journal of medicine.

[28]  P. Bedossa,et al.  An algorithm for the grading of activity in chronic hepatitis C , 1996, Hepatology.

[29]  T. Standiford,et al.  "The good, the bad, and the ugly." The role of chemokines in models of human disease. , 1996, Journal of immunology.

[30]  C. Chu,et al.  T‐cell–mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection , 1995, Hepatology.

[31]  D. Taub,et al.  Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. , 1995, Journal of immunology.

[32]  P. Leder,et al.  The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation , 1995, The Journal of experimental medicine.

[33]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[34]  J. Ludwig,et al.  Liver biopsy features of acute hepatitis C compared with hepatitis A, B, and non-A, non-B, non-C. , 2008, Liver.

[35]  D. Taub,et al.  Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells , 1993, The Journal of experimental medicine.

[36]  S. Gaiani,et al.  Persistent hepatitis C viraemia without liver disease , 1993, The Lancet.

[37]  E. Schiff,et al.  Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. , 1993, Gastroenterology.

[38]  F. Schaffner,et al.  The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis , 1992, Hepatology.

[39]  P. Scheuer,et al.  Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.

[40]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[41]  R. K. Kumar,et al.  Quantitative immunohistologic assessment of lymphocyte populations in the pulmonary inflammatory response to intratracheal silica. , 1989, The American journal of pathology.

[42]  K. Weinbren The pathology of hepatitis. , 1952, The Journal of pathology and bacteriology.